[DPHARMA] QoQ Annualized Quarter Result on 30-Sep-2015 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 5.46%
YoY- -4.62%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 317,210 317,880 270,680 241,705 203,814 182,396 176,961 47.61%
PBT 35,328 39,764 49,755 42,968 41,210 48,792 46,509 -16.76%
Tax -11,790 -8,452 0 -11,714 -11,576 -12,916 0 -
NP 23,538 31,312 49,755 31,253 29,634 35,876 46,509 -36.51%
-
NP to SH 24,692 31,372 38,775 31,253 29,634 35,876 35,271 -21.17%
-
Tax Rate 33.37% 21.26% 0.00% 27.26% 28.09% 26.47% 0.00% -
Total Cost 293,672 286,568 220,925 210,452 174,180 146,520 130,452 71.85%
-
Net Worth 446,334 457,492 270,177 268,509 190,284 205,045 192,942 75.00%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 13,947 - 15,843 - 11,193 - 25,679 -33.45%
Div Payout % 56.49% - 40.86% - 37.77% - 72.81% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 446,334 457,492 270,177 268,509 190,284 205,045 192,942 75.00%
NOSH 278,959 278,959 278,959 278,959 139,915 139,486 138,807 59.32%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 7.42% 9.85% 18.38% 12.93% 14.54% 19.67% 26.28% -
ROE 5.53% 6.86% 14.35% 11.64% 15.57% 17.50% 18.28% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 113.71 113.95 162.30 144.93 145.67 130.76 127.49 -7.34%
EPS 8.44 11.24 19.17 18.72 21.18 25.72 25.41 -52.07%
DPS 5.00 0.00 9.50 0.00 8.00 0.00 18.50 -58.23%
NAPS 1.60 1.64 1.62 1.61 1.36 1.47 1.39 9.84%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 32.98 33.05 28.14 25.13 21.19 18.96 18.40 47.60%
EPS 2.57 3.26 4.03 3.25 3.08 3.73 3.67 -21.15%
DPS 1.45 0.00 1.65 0.00 1.16 0.00 2.67 -33.46%
NAPS 0.464 0.4756 0.2809 0.2791 0.1978 0.2132 0.2006 74.99%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 2.04 2.55 2.62 2.72 2.65 3.88 2.50 -
P/RPS 1.79 2.24 1.61 1.88 1.82 2.97 1.96 -5.87%
P/EPS 23.05 22.67 11.27 14.51 12.51 15.09 9.84 76.47%
EY 4.34 4.41 8.87 6.89 7.99 6.63 10.16 -43.31%
DY 2.45 0.00 3.63 0.00 3.02 0.00 7.40 -52.17%
P/NAPS 1.28 1.55 1.62 1.69 1.95 2.64 1.80 -20.34%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 22/08/16 18/05/16 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 -
Price 2.14 2.40 2.61 2.70 2.40 3.90 2.92 -
P/RPS 1.88 2.11 1.61 1.86 1.65 2.98 2.29 -12.33%
P/EPS 24.18 21.34 11.23 14.41 11.33 15.16 11.49 64.29%
EY 4.14 4.69 8.91 6.94 8.83 6.59 8.70 -39.07%
DY 2.34 0.00 3.64 0.00 3.33 0.00 6.34 -48.57%
P/NAPS 1.34 1.46 1.61 1.68 1.76 2.65 2.10 -25.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment